IDEX Corporation (NYSE: IEX) looks promising with the Zacks research announcing potential highlights of its FY2026, indicating a 25% undervaluation of company's stocks. It strengthened its business with series of acquisitions including
Mott Corporation,
Iridian Spectral Technologies,
STC Material Solutions,
Muon Group,
Airtech, and more to expand its technological capabilities and solutions. Despite mixed reactions from the market and analysts, company stock continues to perform well, providing returns of 26-45% over the past five years.
Financial performances announced in the quarterly earnings calls have had varied results, with some exceeding estimates and others falling short. Their constant push towards innovation and healthy practice of declaring regular quarterly cash dividends has led the analysts to give an average recommendation of
Moderate Buy. However, frequent changes in company's price target and vulnerabilities such as project delays and weakness in their life sciences affect their standings. Despite the headwinds, IDEX Corp continues to show strong prospects and resilience.
Idex Corporation IEX News Analytics from Tue, 08 Oct 2013 07:00:00 GMT to Sat, 01 Feb 2025 07:03:12 GMT -
Rating 5
- Innovation 6
- Information 7
- Rumor -4
